Wockhardt - World class Contract Manufacturing Organisation
  Home
  About Contract Manufacturing
  Our Know How
  Our Facilities
 
Wockhardt - UK
Pinewood - Ireland
Negma Laboratories - France
Morton Grove - USA
Baddi, Himachal Pradesh
Biotech Park (Formulation I & II)
Waluj Cephalosporins
Chikalthana L-1
EoU, Waluj (Oral Solid Division)
Daman, Bhimpore
Daman, Kadaiya
SEZ, Shendra
  Our News
  Contact Us
The Wockhardt Advantage

Wockhardt UK, Wrexham

OVERVIEW

Established in the year: 1950
Facility Area: 16,000 m2
Dosage forms: Small Volume Parenterals - SVP
(cartridges, vials and ampoules)
Lyophilisation
Regulatory approval: USFDA / MHRA (other RoW approvals)

Wockhardt UK has a comprehensive, FDA-approved manufacturing facility for sterile injectables. This facility plays a strategic role in the company's growth plans in:

  • Driving growth through partnerships in contract manufacturing
  • Being an injectable manufacturing base and centre of excellence for global markets.

Over several decades, Wockhardt UK has established its expertise in manufacturing injectables such as cartridges, vials and ampoules (including lyophilised forms) in a variety of sizes. Given its resources, it is not surprising that Wockhardt UK is the partner of choice for reputed international companies for contract manufacturing.

Wockhardt UK is also utilised as a gateway to our comprehensive network of facilities in India. Our business and project managers, together with our local teams in India, are able to manage your molecule to meet your supply chain and business needs.

   Copyright © 2008. Wockhardt. All Rights Reserved. Sitemap  |  www.wockhardt.com
   Website Design by Global Solutions